Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire
Shares of Boston Scientific (BSX) rose sharply Wednesday after the firm posted first-quarter results that topped analysts’ estimates. The Marlborough, Mass.-based medical technology firm reported adjusted earnings per share (EPS) of $0.75 on revenue of $4.66 billion. Analysts surveyed by Visible Alpha expected $0.67 and $4.57 billion, respectively. For the full year, Boston Scientific sees